当前位置: X-MOL 学术J. Enzyme Inhib. Med. Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
New spiro-indeno[1,2-b]quinoxalines clubbed with benzimidazole scaffold as CDK2 inhibitors for halting non-small cell lung cancer; stereoselective synthesis, molecular dynamics and structural insights
Journal of Enzyme inhibition and Medicinal Chemistry ( IF 5.6 ) Pub Date : 2023-11-23 , DOI: 10.1080/14756366.2023.2281260
Assem Barakat 1 , Saeed Alshahrani 1 , Abdullah Mohammed Al-Majid 1 , Abdullah Saleh Alamary 1 , Matti Haukka 2 , Marwa M Abu-Serie 3 , Luis R Domingo 4 , Sajda Ashraf 5 , Zaheer Ul-Haq 5 , Mohamed S Nafie 6, 7 , Mohamed Teleb 8
Affiliation  

Despite the crucial role of CDK2 in tumorigenesis, few inhibitors reached clinical trials for managing lung cancer, the leading cause of cancer death. Herein, we report combinatorial stereoselectiv...

中文翻译:

新型螺茚并[1,2-b]喹喔啉与苯并咪唑支架结合作为 CDK2 抑制剂,用于阻止非小细胞肺癌;立体选择性合成、分子动力学和结构见解

尽管CDK2在肿瘤发生中发挥着至关重要的作用,但很少有抑制剂能够进入治疗肺癌(癌症死亡的主要原因)的临床试验。在此,我们报告了组合立体选择性...
更新日期:2023-11-23
down
wechat
bug